Skip to main content

Prostate Cancer Outcomes Comparable for Transgender Women, Cisgender Men

Medically reviewed by Carmen Pope, BPharm. Last updated on July 26, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 26, 2024 -- Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate cancer-specific mortality, according to a study published online July 21 in Cancer.

Margaret Meagher, M.D., from the University of California San Diego School of Medicine in La Jolla, and colleagues compared oncological characteristics and survival outcomes between TGW and CG men with prostate cancer using data from the Veterans Affairs Informatics and Computing Infrastructure database (1999 to 2020) and the Surveillance, Epidemiology, and End Results-Medicare database (2010 to 2017). The groups were matched in a 5:1 ratio (CG:TGW) based on age, race, year of diagnosis, and Charlson Comorbidity Index score. Data were included for 1,194 patients: 199 TGW and 995 CG.

The researchers found that there were no significant associations between transgender identity and metastatic presentation, high-risk localized disease, or prostate cancer-specific mortality. There was a significant association seen between transgender identity and improved overall survival.

"In contrast to previous studies, we did not detect worsened prostate cancer outcomes within [the transgender] community," the authors write. "These conflicting data highlight the need for further investigation."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

Sexual and Gender Minority Adults Have Higher Risk of Epilepsy

WEDNESDAY, July 24, 2024 -- Sexual and gender minority adults in the United States have a disproportionate prevalence of epilepsy, according to a study published online July 22...

Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer

FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study...

Psychological Risks Increased for Transgender Youth at Gender Identity Milestones

MONDAY, July 15, 2024 -- Transgender youth have an increased risk for attempting suicide or running away from home in association with gender identity milestones, with the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.